Barchart.com
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB)
0.5601 x 8 0.5800 x 5
Post-market by (Cboe BZX)
0.6600 +0.0700 (+11.86%) 04/14/25 [NASDAQ]
0.5601 x 8 0.5800 x 5
Post-market 0.5600 -0.1000 (-15.15%) 16:33 ET
News & Headlines for Mon, Apr 14th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates GlobeNewswire - Thu Mar 13, 6:00AM CDT

MCRB : 0.6633 (+12.33%)
Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025 GlobeNewswire - Tue Mar 4, 6:00AM CST

MCRB : 0.6633 (+12.33%)
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach GlobeNewswire - Mon Mar 3, 6:00AM CST

MCRB : 0.6633 (+12.33%)
Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale GlobeNewswire - Thu Jan 16, 6:00AM CST

MCRB : 0.6633 (+12.33%)
Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates GlobeNewswire - Thu Jan 9, 6:00AM CST

MCRB : 0.6633 (+12.33%)
Seres Therapeutics to Present at J.P. Morgan Healthcare Conference, Highlighting SER-155 Breakthrough Therapy Designation Quiver Quantitative, Inc. - Mon Dec 16, 2024

Seres Therapeutics will present at the J.P. Morgan Healthcare Conference, focusing on SER-155's potential to reduce bloodstream infections.Quiver AI SummarySeres Therapeutics, Inc. has announced that CEO...

MCRB : 0.6633 (+12.33%)
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference GlobeNewswire - Mon Dec 16, 2024

MCRB : 0.6633 (+12.33%)
Seres Therapeutics Announces FDA Breakthrough Therapy Designation for SER-155 Following Promising Phase 1b Clinical Results Quiver Quantitative, Inc. - Mon Dec 9, 2024

The FDA granted SER-155 Breakthrough Therapy designation for reducing bloodstream infections in allo-HSCT patients, supported by promising Phase 1b clinical data.Quiver AI SummarySeres Therapeutics announced...

MCRB : 0.6633 (+12.33%)
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) GlobeNewswire - Mon Dec 9, 2024

MCRB : 0.6633 (+12.33%)
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference GlobeNewswire - Fri Nov 22, 2024

MCRB : 0.6633 (+12.33%)
Seres Therapeutics: Q3 Earnings Snapshot AP - Wed Nov 13, 2024

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.6633 (+12.33%)
Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates GlobeNewswire - Wed Nov 13, 2024

MCRB : 0.6633 (+12.33%)
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024 GlobeNewswire - Wed Nov 6, 2024

MCRB : 0.6633 (+12.33%)
Seres Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 13, 2024

Seres Therapeutics: Q2 Earnings Snapshot

MCRB : 0.6633 (+12.33%)
Seres Therapeutics: Q1 Earnings Snapshot AP - Wed May 8, 2024

Seres Therapeutics: Q1 Earnings Snapshot

MCRB : 0.6633 (+12.33%)
Seres Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 2, 2023

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.6633 (+12.33%)
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 13.27 (+4.49%)
FHTX : 3.59 (+4.06%)
MRNA : 26.80 (+2.29%)
OMGA : 0.1426 (-10.82%)
SANA : 1.8100 (+2.84%)
MCRB : 0.6633 (+12.33%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 13.27 (+4.49%)
FHTX : 3.59 (+4.06%)
MRNA : 26.80 (+2.29%)
OMGA : 0.1426 (-10.82%)
SANA : 1.8100 (+2.84%)
MCRB : 0.6633 (+12.33%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List PR Newswire - Wed Sep 27, 2023

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 13.27 (+4.49%)
FHTX : 3.59 (+4.06%)
MRNA : 26.80 (+2.29%)
OMGA : 0.1426 (-10.82%)
SANA : 1.8100 (+2.84%)
MCRB : 0.6633 (+12.33%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire - Mon Sep 11, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 13.27 (+4.49%)
FHTX : 3.59 (+4.06%)
MRNA : 26.80 (+2.29%)
OMGA : 0.1426 (-10.82%)
SANA : 1.8100 (+2.84%)
MCRB : 0.6633 (+12.33%)

Barchart Exclusives

Should You Buy Apple Stock on the ‘Liberation Day’ Dip? Barchart - 6 minutes ago
Down almost 25% from all-time highs, Apple stock is unlikely to deliver outsized gains to long-term shareholders despite the ongoing pullback in valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot